Association Between MGMT Promoter Hypermethylation and p53 Mutation in Glioblastoma

被引：30

作者：

Shamsara, Jamal ^{[2
]}

Sharif, Samaneh

Afsharnezhad, Sima ^{[5
]}

Lotfi, Marzieh ^{[3
]}

Raziee, Hamid Reza ^{[4
]}

Ghaffarzadegan, Kamran ^{[3
]}

Moradi, Afshin ^{[6
]}

Rahighi, Saeed ^{[5
]}

Behravan, Javad ^{[1
,2
]}

机构：

[1] Sch Pharm, Dept Pharmacognosy & Biotechnol, Biotechnol Lab, Biotechnol Res Ctr, Mashhad, Iran

[2] Mashhad Univ Med Sci, Canc Res Ctr, Omid Hosp, Dept Biotechnol,Sch Pharm, Mashhad, Iran

[3] Mashhad Univ Med Sci, Canc Res Ctr, Omid Hosp, Dept Pathol, Mashhad, Iran

[4] Mashhad Univ Med Sci, Canc Res Ctr, Omid Hosp, Dept Radiat Oncol, Mashhad, Iran

[5] Azad Univ Mashhad, Dept Biochem, Sch Med, Mashhad, Iran

[6] Shaheed Beheshti Univ, Shohada Hosp, Sch Med, Tehran, Iran

来源：

CANCER INVESTIGATION | 2009年 / 27卷 / 08期

关键词：

Hypermethylation; Glioblastoma; O6-methylguanine-DNA methyltransferase; p53; DNA-REPAIR GENE; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; ALKYLATING-AGENTS; PREDICTS RESPONSE; G-C; CANCER; METHYLATION; INACTIVATION; TEMOZOLOMIDE; PATHWAYS;

D O I：

10.1080/07357900902783211

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

O6-methylguanine-DNA methyltransferase (MGMT) is a DNA repair enzyme that removes alkyl groups from the O6 position of guanine. MGMT is transcriptionally silenced by promoter hypermethylation in several human neoplasia. We used methylation-specific PCR (MSP) to analyze the MGMT promoter methylation status of 50 glioblastoma tumors. Hypermethylation was detected in 24 of 50 (48%) samples. We also analyzed mutant p53 expression by immunohistochemical analysis of glaioblastoma tissue samples. A significant association was found between MGMT methylation and p53 mutation status (p .05). These results suggested that epigenetic inactivation of MGMT plays an important role in the survival of glioblastoma patients and this inactivated gene involved in p53 mutation.

引用

页码：825 / 829

页数：5

共 50 条

[31] Cross-talk between the O(6)-Methylguanine-DNA methyltransferase (MGMT) and p53 in glioblastoma multiforme.
Patyka, Mariia
Abdulkarim, Bassam
Xu, Yaoxian
Sabri, Siham
[J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
[32] The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma
Villani, Veronica
Casini, Beatrice
Pace, Andrea
Prosperini, Luca
Carapella, Carmine M.
Vidiri, Antonello
Fabi, Alessandra
Carosi, Andmariantonia
[J]. DISEASE MARKERS, 2015, 2015
[33] COMPARATIVE ANALYSIS OF IDH1 MUTATION, TP53 MUTATION, AND MGMT HYPERMETHYLATION IN ASTROCYTOMAS
Eoli, M.
Di Stefano, A.
Valletta, L.
Guzzetti, S.
Maderna, E.
Pollo, B.
Finocchiaro, G.
[J]. NEURO-ONCOLOGY, 2010, 12 : 52 - 52
[34] The combined effect of neutron irradiation and temozolomide on glioblastoma cell lines with different MGMT and P53 status
Kinashi, Yuko
Ikawa, Tomoyuki
Takahashi, Sentaro
[J]. APPLIED RADIATION AND ISOTOPES, 2020, 163 (163)
[35] P53 promoter selection - Choosing between life and death
Das, Sanjeev
Boswell, Sarah A.
Aaronson, Stuart A.
Lee, Sam W.
[J]. CELL CYCLE, 2008, 7 (02) : 154 - 157
[36] LACK OF ASSOCIATION BETWEEN UV-INDUCED P53 MUTATION AND SUNEXPOSED CUTANEOUS CARCINOMAS
COOK, T
FOSKO, SW
COOK, SS
LEONARDI, CL
[J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (04) : 634 - 634
[37] Mutation and methylation status of p53 gene promoter in human breast tumours
Nayak, BK
Das, BR
[J]. TUMOR BIOLOGY, 1999, 20 (06) : 341 - 346
[38] MGMT PROMOTER HYPERMETHYLATION AND P53 IMMUNOHISTOCHEMISTRY PREDICT OUTCOME FOLLOWING TEMOZOLOMIDE FOR RECURRENT 1P/19Q NON-DELETED ANAPLASTIC (OLIGO)ASTROCYTOMA
Sadones, J.
Michotte, A.
Veld, P. In't
Chaskis, C.
Menten, J.
Joosens, E.
Strauven, T.
Califice, S.
De Greve, J.
Neyns, B.
[J]. NEURO-ONCOLOGY, 2008, 10 (06) : 1129 - 1129
[39] Preproenkephalin hypermethylation in the pure pancreatic juice compared with p53 mutation in the diagnosis of pancreatic carcinoma
Ohtsubo, Koushiro
Watanabe, Hiroyuki
Yao, Fan
Okada, Gensaku
Mouri, Hisatsugu
Yamaguchi, Yasushi
Sawabu, Norio
[J]. JOURNAL OF GASTROENTEROLOGY, 2006, 41 (08) : 791 - 797
[40] Preproenkephalin hypermethylation in the pure pancreatic juice compared with p53 mutation in the diagnosis of pancreatic carcinoma
Koushiro Ohtsubo
Hiroyuki Watanabe
Fan Yao
Gensaku Okada
Hisatsugu Mouri
Yasushi Yamaguchi
Norio Sawabu
[J]. Journal of Gastroenterology, 2006, 41 : 791 - 797

← 1 2 3 4 5 →